Cargando…
Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling
BACKGROUND: Jujuboside B (JUB) is a saponins isolated from the seeds of Zizyphi jujuba var. spinosi, which is used to treat mental illness and is reported recently to induce cancer cell apoptosis. As our previous research showed chronic stress promoted tumor growth, this work aims to investigate whe...
Autores principales: | Yang, Zhen, Cai, Weijia, Chen, Yitian, Guo, Zhijun, Xiao, Zhijun, Zhou, Ting, Cheng, Yuanchi, Xu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569198/ https://www.ncbi.nlm.nih.gov/pubmed/36254198 http://dx.doi.org/10.1155/2022/5211368 |
Ejemplares similares
-
Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005) -
Jujuboside B suppresses angiogenesis and tumor growth via blocking VEGFR2 signaling pathway
por: Zhang, Pan, et al.
Publicado: (2023) -
The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
por: Du, Juan, et al.
Publicado: (2016) -
Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells
por: Hong, Zhong, et al.
Publicado: (2020) -
Jujuboside A Protects H9C2 Cells from Isoproterenol-Induced Injury via Activating PI3K/Akt/mTOR Signaling Pathway
por: Han, Dandan, et al.
Publicado: (2016)